Predictors of Urinary Tract Infections in Children and Antibiotic Susceptibility Pattern in the Buea Health District, South West Region, Cameroon
Overview
Biotechnology
General Medicine
Affiliations
Urinary tract infections (UTI) are among the most common pediatric infections and if not promptly diagnosed and treated, it could cause long term complications. Worldwide and in Cameroon, little attention has been paid to this growing problem in the pediatric population. Identification of risk factors will contribute significantly to prevention. A cross-sectional case-control study was carried out in children ≤ 15 years to identify the risk factors of UTI, etiologic agents, and their antibiotic susceptibility. Samples (urine) were collected from in and outpatients with symptoms of UTI attending two health facilities in Buea. Controls were age- and sex-matched children in the community and those visiting these health facilities for unrelated reasons. Samples were analyzed by microscopy, culture, and antibiotic susceptibility of bacteria isolates tested by the disc diffusion technique. Questionnaires were administered to collect sociodemographic, clinical characteristics and data on risk factors. Odds ratios and bivariate and multivariate analyses were used to assess the relationship between predictors (symptoms and risk factors) and UTI. < 0.05 was considered significant. A total of 405 participants (200 cases and 205 controls) were investigated. UTI prevalence was 12% in cases. From the UTI cases, bacteria was the major cause of infection, with (39.4%) predominating. Parasitic organisms, (0.5%) and (0.5%), and yeast (6%) were also detected. Urinary urgency ( = 4.98, = 0.027) and back pain ( = 12.37, = 0.001) were associated to UTI following bivariate analysis. These parameters could be used to predict UTI in the pediatric population in the study area. Third generation cephalosporins: ceftriaxone (90.1%) and cefadroxil (85.4%) were the most effective and thus recommended for treatment.
Kowalski M, Obama B, Catho G, Dewez J, Merglen A, Ruef M EClinicalMedicine. 2024; 70:102512.
PMID: 38495519 PMC: 10940950. DOI: 10.1016/j.eclinm.2024.102512.
Beyond schistosomiasis: unraveling co-infections and altered immunity.
Perera D, Koger-Pease C, Paulini K, Daoudi M, Ndao M Clin Microbiol Rev. 2024; 37(1):e0009823.
PMID: 38319102 PMC: 10938899. DOI: 10.1128/cmr.00098-23.
Sunday A, Nyasa R, Mokake M PLOS Glob Public Health. 2023; 3(4):e0001854.
PMID: 37186243 PMC: 10132537. DOI: 10.1371/journal.pgph.0001854.
Yimgang L, Toghueo R, Kanko Mbekou I, Dize D, Boyom F PLoS One. 2022; 17(5):e0267246.
PMID: 35544583 PMC: 9094522. DOI: 10.1371/journal.pone.0267246.
Campbell J, van Henten S, Koroma Z, Kamara I, Kamara G, Shewade H Int J Environ Res Public Health. 2022; 19(8).
PMID: 35457729 PMC: 9024669. DOI: 10.3390/ijerph19084865.